These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 10730637)

  • 1. Prognostic factors in recurrent glioblastoma multiforme and anaplastic astrocytoma treated with selective intra-arterial chemotherapy.
    Chow KL; Gobin YP; Cloughesy T; Sayre JW; Villablanca JP; Viñuela F
    AJNR Am J Neuroradiol; 2000 Mar; 21(3):471-8. PubMed ID: 10730637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-arterial Cereport (RMP-7) and carboplatin: a dose escalation study for recurrent malignant gliomas.
    Cloughesy TF; Black KL; Gobin YP; Farahani K; Nelson G; Villablanca P; Kabbinavar F; Viñeula F; Wortel CH
    Neurosurgery; 1999 Feb; 44(2):270-8; discussion 278-9. PubMed ID: 9932880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging response to chemotherapy with RMP-7 and carboplatin in malignant glioma: size matters but speed does not.
    Grant R; Walker M; Hadley D; Barton T; Osborn C
    J Neurooncol; 2002 May; 57(3):241-5. PubMed ID: 12125987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-arterial carboplatin as a salvage strategy in the treatment of recurrent glioblastoma multiforme.
    Fortin D; Morin PA; Belzile F; Mathieu D; Paré FM
    J Neurooncol; 2014 Sep; 119(2):397-403. PubMed ID: 24947313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superselective intra-arterial carboplatin for treatment of intracranial neoplasms: experience in 100 procedures.
    Qureshi AI; Suri MF; Khan J; Sharma M; Olson K; Guterman LR; Hopkins LN
    J Neurooncol; 2001 Jan; 51(2):151-8. PubMed ID: 11386412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodality management of recurrent adult malignant gliomas: results of a phase II multiagent chemotherapy study and analysis of cytoreductive surgery.
    Rostomily RC; Spence AM; Duong D; McCormick K; Bland M; Berger MS
    Neurosurgery; 1994 Sep; 35(3):378-88; discussion 388. PubMed ID: 7800129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma.
    Prados MD; Schold SC; Fine HA; Jaeckle K; Hochberg F; Mechtler L; Fetell MR; Phuphanich S; Feun L; Janus TJ; Ford K; Graney W
    Neuro Oncol; 2003 Apr; 5(2):96-103. PubMed ID: 12672281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination chemotherapy using carboplatin (JM-8) and etoposide (JET therapy) for recurrent malignant gliomas: a phase II study.
    Watanabe K; Kanaya H; Fujiyama Y; Kim P
    Acta Neurochir (Wien); 2002 Dec; 144(12):1265-70; discussion 1270. PubMed ID: 12478337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment ADC histogram analysis is a predictive imaging biomarker for bevacizumab treatment but not chemotherapy in recurrent glioblastoma.
    Ellingson BM; Sahebjam S; Kim HJ; Pope WB; Harris RJ; Woodworth DC; Lai A; Nghiemphu PL; Mason WP; Cloughesy TF
    AJNR Am J Neuroradiol; 2014 Apr; 35(4):673-9. PubMed ID: 24136647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-arterial carboplatin chemotherapy for brain tumors: a dose escalation study based on cerebral blood flow.
    Cloughesy TF; Gobin YP; Black KL; Viñuela F; Taft F; Kadkhoda B; Kabbinavar F
    J Neurooncol; 1997 Nov; 35(2):121-31. PubMed ID: 9266448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas.
    Kowalczuk A; Macdonald RL; Amidei C; Dohrmann G; Erickson RK; Hekmatpanah J; Krauss S; Krishnasamy S; Masters G; Mullan SF; Mundt AJ; Sweeney P; Vokes EE; Weir BK; Wollman RL
    Neurosurgery; 1997 Nov; 41(5):1028-36; discussion 1036-8. PubMed ID: 9361056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preirradiation ifosfamide, carboplatin, and etoposide for the treatment of anaplastic astrocytomas and glioblastoma multiforme: a phase II study.
    López-Aguilar E; Sepúlveda-Vildósola AC; Rivera-Márquez H; Cerecedo-Díaz F; Hernández-Contreras I; Ramón-García G; Diegopérez-Ramírez J; Santacruz-Castillo E
    Arch Med Res; 2000; 31(2):186-90. PubMed ID: 10880725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early post-bevacizumab progression on contrast-enhanced MRI as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 Central Reader Study.
    Boxerman JL; Zhang Z; Safriel Y; Larvie M; Snyder BS; Jain R; Chi TL; Sorensen AG; Gilbert MR; Barboriak DP
    Neuro Oncol; 2013 Jul; 15(7):945-54. PubMed ID: 23788270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A first feasibility study of temozolomide for Japanese patients with recurrent anaplastic astrocytoma and glioblastoma multiforme.
    Aoki T; Mizutani T; Ishikawa M; Sugiyama K; Hashimoto N
    Int J Clin Oncol; 2003 Oct; 8(5):301-4. PubMed ID: 14586755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response and progression in recurrent malignant glioma.
    Hess KR; Wong ET; Jaeckle KA; Kyritsis AP; Levin VA; Prados MD; Yung WK
    Neuro Oncol; 1999 Oct; 1(4):282-8. PubMed ID: 11550320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective intra-arterial chemotherapy with BCNU in recurrent malignant gliomas.
    Bradac GB; Soffietti R; Riva A; Stura G; Sales S; Schiffer D
    Neuroradiology; 1992; 34(1):73-6. PubMed ID: 1313161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I trial of carboplatin administered by convection-enhanced delivery to patients with recurrent/progressive glioblastoma multiforme.
    White E; Bienemann A; Taylor H; Hopkins K; Cameron A; Gill S
    Contemp Clin Trials; 2012 Mar; 33(2):320-31. PubMed ID: 22101221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic susceptibility contrast MRI measures of relative cerebral blood volume as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 multicenter trial.
    Schmainda KM; Zhang Z; Prah M; Snyder BS; Gilbert MR; Sorensen AG; Barboriak DP; Boxerman JL
    Neuro Oncol; 2015 Aug; 17(8):1148-56. PubMed ID: 25646027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using proton magnetic resonance spectroscopic imaging to predict in vivo the response of recurrent malignant gliomas to tamoxifen chemotherapy.
    Preul MC; Caramanos Z; Villemure JG; Shenouda G; LeBlanc R; Langleben A; Arnold DL
    Neurosurgery; 2000 Feb; 46(2):306-18. PubMed ID: 10690719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical trial of bradykinin-enhancing chemotherapy for a recurrent malignant glioma: a case report].
    Inamura T; Ikezaki K; Hirokawa E; Kawamura T; Yoshiura T; Mihara F; Sueyasu M; Irita K; Takahashi S; Fukui M
    No Shinkei Geka; 2001 Nov; 29(11):1107-13. PubMed ID: 11758319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.